Gilenya (Fingolimod)

Fingolimod · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gilenya (Fingolimod), covering 2012-06-26 to 2012-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis [Phase 3]